Login

Peter Nählstedt. CEO, SenzaGen 00:00:00

Share On Facebook Share On Twitter

SenzaGen's CEO Peter Nählstedt presents the company

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Biocept's Liquid Biopsy Innovations: CEO Mike Nall Discusses 2019 Achievements and 2020 Outlook
00:10:00
Backing brilliant, autistic, eccentric, and controversial founders powering the future of open Market|Tamara Frankel,Founding Partner,D1 Capital
00:10:00
A More Involved Way To Do Capital|Senofer Mendoza,Founder and General Partner,Mendoza Ventures
00:10:00
Backs entrepreneurs shifting the future of aerospace|Thomas d’Halluin,Managing Partner,Airbus Ventures
00:10:00
David Bramhill at 121 Oil & Gas Investment London: Insights into Union Jack Oil's Strategy and Market Position | David Bramhill, Executive Chairman, Union Jack Oil Plc.
00:10:00
wealth grow Investment opportunities|MARK HENTEMANN,CEO,Quantum Capital
00:10:00
Ekopak's adoption of Factry’s Historian software has revolutionized their operations, enhancing process efficiency and business outcomes significantly.
00:10:00
signifying leadership within a VC firm, overseeing investment decisions and firm strategy.|Amy Saper,Partner,Accel
00:10:00
Baselode Energy: Early-Stage Uranium Exploration in Canada's Athabasca Basin
00:10:00
Global Market Insights and Investment Strategies with Stephen Gilmore, CIO of New Zealand Super Fund | Capital Allocators Manager Meetings
00:10:00
Krsnaa Diagnostics Ltd. IPO: A Deep Dive into the Company’s Business and Financials | Yash Mutha, Director ,Krsnaa Diagnostics Ltd.
00:10:00
Akobo Minerals Highlights 2023 Success and 2024 Plans with New Processing Plant and Underground Mine Progress

© 2026 Nehu